市场调查报告书
商品编码
1500517
兽医诊断设备市场:按测试类型、产品类型、动物种类和最终用户 - 2024-2030 年全球预测Veterinary Diagnostic Equipment Market by Testings Type (Bacteriology, Clinical Chemistry Test, Diagnostic Imaging), Product Type (Consumables, Reagents & Kits, Instruments & Devices), Species, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年兽医诊断设备市场规模为27.6亿美元,2024年达29.6亿美元,预计2030年将达到45.5亿美元,复合年增长率为7.36%。
兽医诊断设备由专门设计用于诊断动物疾病、状况和整体健康状况的各种工具和系统组成。该设备在兽医学中发挥着重要作用,兽医和兽医技术人员可以准确评估和监测宠物、牲畜和其他动物的健康状况。这些诊断工具采用先进技术,从X光设备和超音波设备等诊断影像设备到血液分析仪和PCR机等临床检测设备。这些设备提供的准确及时的诊断对于制定有效的治疗计划和确保动物健康至关重要。宠物拥有量的增加和宠物照护费用的增加,以及动物疾病盛行率的上升,正在推动对兽医诊断设备的需求。此外,人类消费的动物源产品的增加强调了牲畜健康的重要性,并增加了对有效诊断解决方案的需求。然而,先进诊断设备的高成本和新兴市场的低知名度可能会阻碍市场成长。也就是说,分子诊断、免疫诊断分析和即时护理设备的技术创新是探索和扩展的成熟领域,并可能为市场成长开闢新的途径。
主要市场统计 | |
---|---|
基准年[2023] | 27.6亿美元 |
预测年份 [2024] | 29.6亿美元 |
预测年份 [2030] | 45.5亿美元 |
复合年增长率(%) | 7.36% |
区域洞察
美洲地区代表了兽医诊断设备的强劲市场。由于宠物拥有率高、动物保健支出高以及主要市场参与者的强大影响力,美国在市场规模和技术进步方面处于领先地位。由于动物健康意识的提高和宠物主人可支配收入的增加,包括巴西和墨西哥在内的拉丁美洲国家正在经历该行业的成长。 EMEA(欧洲、中东和非洲)地区呈现出多元化的市场格局。欧洲因其高标准的兽医护理、严格的动物健康法规和大量的研发投资而在市场成熟度方面处于领先地位。中东和非洲地区是一个具有高成长潜力的新兴市场,受到宠物拥有率上升、畜牧业扩张以及动物健康意识不断增强的支持。由于宠物拥有率上升、畜牧业扩张以及兽医医疗保健支出增加,亚太地区兽医诊断设备市场正在快速成长。中国、印度、日本和澳洲等国家正在引领该地区的成长。该市场的特点是先进技术和基本诊断工具的结合,满足都市区地区的多样化需求。该地区动物健康基础设施和兽医服务投资的增加,以及提供广泛诊断解决方案的国内和国际公司的进入,正在进一步推动市场成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在兽医诊断设备市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对兽医诊断设备市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在兽医诊断设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[199 Pages Report] The Veterinary Diagnostic Equipment Market size was estimated at USD 2.76 billion in 2023 and expected to reach USD 2.96 billion in 2024, at a CAGR 7.36% to reach USD 4.55 billion by 2030.
Veterinary Diagnostic Equipment comprises a diverse range of tools and systems designed specifically for diagnosing diseases, conditions, and the overall health status of animals. This equipment plays a crucial role in the veterinary sector by enabling veterinarians and veterinary technicians to accurately assess & monitor the health of pets, livestock, and other animals. Utilizing advanced technology, these diagnostic tools range from imaging equipment, such as X-ray & ultrasound machines, to clinical laboratory devices, such as blood analyzers and PCR machines. The precise and timely diagnoses provided by these instruments are essential for effective treatment planning and ensuring the well-being of animals. Increasing pet adoption and expenditure on pet care, coupled with a rising prevalence rate of diseases among animals, has increased the need for veterinary diagnostic equipment. Furthermore, the growth of animal-derived products for human consumption underlines the importance of livestock health, amplifying the need for efficient diagnostic solutions. However, the high cost of advanced diagnostic equipment and lack of awareness in emerging markets may hamper the market growth. Nevertheless, innovations in molecular diagnostics, immune-diagnostic assays, and point-of-care devices represent areas ripe for exploration and expansion, potentially opening new avenues for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.76 billion |
Estimated Year [2024] | USD 2.96 billion |
Forecast Year [2030] | USD 4.55 billion |
CAGR (%) | 7.36% |
Regional Insights
The Americas region exhibits a robust market for veterinary diagnostic equipment. The United States leads in terms of market size and technological advancements, driven by high pet ownership rates, substantial veterinary healthcare expenditures, and a strong presence of leading market players. Countries in Latin America including Brazil , Mexico are experiencing growth in this sector due to increasing awareness about animal health and rising disposable incomes among pet owners. The EMEA region presents a diverse market landscape. Europe is at the forefront in terms of market maturity, driven by high standards of veterinary care, stringent animal health regulations, and significant R&D investments. The MEA region is an emerging market with potential for high growth, supported by increasing pet adoption rates, expanding livestock sectors, and growing awareness about animal health. The Asia Pacific region showcases rapid growth in the veterinary diagnostic equipment market, attributed to rising pet ownership, expanding livestock industries, and increasing expenditures on animal healthcare. Countries including China, India, Japan, and Australia are leading the growth in this region. The market is characterized by a mix of advanced technologies and basic diagnostic tools, catering to diverse needs across urban and rural areas. Growing investments in animal health infrastructure and veterinary services in the region and the expansion of local and international companies in the region, offering a wide range of diagnostic solutions, are further supporting the growth of the market.
Market Insights
The market dynamics represent an ever-changing landscape of the Veterinary Diagnostic Equipment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Diagnostic Equipment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Diagnostic Equipment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Center Point Bio-Tech's Launch of Novel Veterinary Diagnostic System Exceeds Expectations
Center Point Bio-Tech, LLC launched AlphaION, a veterinary diagnostic system that combines lab automation with artificial intelligence to enhance workflow in veterinary practices, offering comprehensive testing capabilities through its modular design, including blood, fecal, urine, and bacterial tests. AlphaION distinguishes itself as a diagnostic system that integrates Surface Acoustic Wave (SAW) technology for precise biomarker measurement and introduces in-clinic automation for bacterial culture and sensitivity testing, addressing common issues such as false negatives and testing delays associated with external labs. [Published On: 2024-01-24]
Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
Antech expanded its UK laboratory network by opening a new, cutting-edge veterinary diagnostics facility to strengthen its presence in the region. Antech introduces to the UK its first comprehensive veterinary diagnostics solution, encompassing reference laboratory services, in-lab diagnostics, advanced imaging, technology solutions, telemedicine services, and pioneering rapid diagnostics. [Published On: 2023-11-07]
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing
IDEXX Laboratories, Inc. has introduced a diagnostic test designed to detect kidney injury in cats and dogs, the IDEXX Cystatin B Test. This significant advancement addresses a critical need in pet healthcare, as roughly one-third of kidney issues managed by veterinarians involve injury, often challenging to diagnose due to ambiguous symptoms. The IDEXX Cystatin B Test, alongside the existing IDEXX SDMA and other renal health tests, seeks to offer a comprehensive kidney health evaluation, enabling early intervention and improved treatment outcomes. [Published On: 2023-06-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Diagnostic Equipment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Diagnostic Equipment Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Agrolabo S.p.A., Bio-Rad Laboratories, Inc., BioChek B.V., Biomerieux SA, Carestream Health Inc., Covetrus, Inc., Diagnostic Imaging Systems, Inc., Heska Corporation, Hill-Rom Holdings, Inc., IDEXX Laboratories, Inc., IM3 Inc., IMV Technologies group, INDICAL Bioscience GmbH, Innovative Diagnostics SAS, Merck & Co., Inc., Mindray Medical International Ltd., MinXray, Inc., Neogen Corporation, Randox Laboratories, Ltd., scil animal care company GmbH, Thermo Fisher Scientific, Inc., Virbac, Inc., and Zoetis, Inc..
Market Segmentation & Coverage